Uploaded image for project: 'eCQM Known Issues'
  1. eCQM Known Issues
  2. EKI-27

CMS117v11 and CMS117v12

XMLWordPrintable

    • Icon: EP/EC EP/EC
    • Resolution: Unresolved
    • Icon: Moderate Moderate
    • None
    • Hide
      Implementers can map the use of 20-valent pneumococcal conjugate vaccine (PCV20) (CVX code 216) to the ‘pneumococcal vaccine, unspecified formulation’ code (CVX code 109) or the ‘Pneumococcal Conjugate, unspecified formulation’ code (CVX code 152) in the 'Pneumococcal Conjugate Vaccine' (OID: 2.16.840.1.113883.3.464.1003.196.12.1221) value set.
      Show
      Implementers can map the use of 20-valent pneumococcal conjugate vaccine (PCV20) (CVX code 216) to the ‘pneumococcal vaccine, unspecified formulation’ code (CVX code 109) or the ‘Pneumococcal Conjugate, unspecified formulation’ code (CVX code 152) in the 'Pneumococcal Conjugate Vaccine' (OID: 2.16.840.1.113883.3.464.1003.196.12.1221) value set.
    • 2023; 2024

      eCQMs Impacted – CMS117v11 and CMS117v12: Childhood Immunization Status

      Issue – Due to publication timeline, the measures do not include the recently updated Advisory Committee on Immunization Practices guidelines to include code for specific formulation, PCV20 pneumococcal vaccine formulation, to meet numerator requirements.

            Unassigned Unassigned
            edave Mathematica EC eCQM Team
            Votes:
            6 Vote for this issue
            Watchers:
            13 Start watching this issue

              Created:
              Updated: